Literature DB >> 34202815

Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.

Mahendra Rai1, Shital Bonde1, Alka Yadav1, Arpita Bhowmik2, Sanjay Rathod3, Pramod Ingle1, Aniket Gade1.   

Abstract

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health problem that the WHO declared a pandemic. COVID-19 has resulted in a worldwide lockdown and threatened to topple the global economy. The mortality of COVID-19 is comparatively low compared with previous SARS outbreaks, but the rate of spread of the disease and its morbidity is alarming. This virus can be transmitted human-to-human through droplets and close contact, and people of all ages are susceptible to this virus. With the advancements in nanotechnology, their remarkable properties, including their ability to amplify signal, can be used for the development of nanobiosensors and nanoimaging techniques that can be used for early-stage detection along with other diagnostic tools. Nano-based protection equipment and disinfecting agents can provide much-needed protection against SARS-CoV-2. Moreover, nanoparticles can serve as a carrier for antigens or as an adjuvant, thereby making way for the development of a new generation of vaccines. The present review elaborates the role of nanotechnology-based tactics used for the detection, diagnosis, protection, and treatment of COVID-19 caused by the SARS-CoV-2 virus.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; detection; nanotechnology; treatment

Mesh:

Substances:

Year:  2021        PMID: 34202815     DOI: 10.3390/v13071224

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  46 in total

1.  RNA interference-based therapeutics and diagnostics.

Authors:  Dan Peer; Kenneth A Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

Review 2.  Nanomaterials for diagnosis: challenges and applications in smart devices based on molecular recognition.

Authors:  Osvaldo N Oliveira; Rodrigo M Iost; José R Siqueira; Frank N Crespilho; Luciano Caseli
Journal:  ACS Appl Mater Interfaces       Date:  2014-07-09       Impact factor: 9.229

Review 3.  Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination.

Authors:  Janina M Jansen; Thomas Gerlach; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  J Clin Virol       Date:  2019-08-24       Impact factor: 3.168

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.

Authors:  Roy Fleischmann; Mark C Genovese; Yong Lin; Gregory St John; Désirée van der Heijde; Sheldon Wang; Juan Jose Gomez-Reino; Jose Antonio Maldonado-Cocco; Marina Stanislav; Alan J Kivitz; Gerd R Burmester
Journal:  Rheumatology (Oxford)       Date:  2020-02-01       Impact factor: 7.580

6.  Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.

Authors:  Cuiqing Ma; Lili Wang; Xinrong Tao; Naru Zhang; Yang Yang; Chien-Te K Tseng; Fang Li; Yusen Zhou; Shibo Jiang; Lanying Du
Journal:  Vaccine       Date:  2014-09-19       Impact factor: 3.641

Review 7.  Immune-mediated approaches against COVID-19.

Authors:  Helena F Florindo; Ron Kleiner; Daniella Vaskovich-Koubi; Rita C Acúrcio; Barbara Carreira; Eilam Yeini; Galia Tiram; Yulia Liubomirski; Ronit Satchi-Fainaro
Journal:  Nat Nanotechnol       Date:  2020-07-13       Impact factor: 40.523

Review 8.  SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.

Authors:  Allison L Totura; Ralph S Baric
Journal:  Curr Opin Virol       Date:  2012-05-07       Impact factor: 7.090

9.  Insights from nanotechnology in COVID-19 treatment.

Authors:  Zhongmin Tang; Xingcai Zhang; Yiqing Shu; Ming Guo; Han Zhang; Wei Tao
Journal:  Nano Today       Date:  2020-11-04       Impact factor: 20.722

Review 10.  Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.

Authors:  Vibhuti Kumar Shah; Priyanka Firmal; Aftab Alam; Dipyaman Ganguly; Samit Chattopadhyay
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more
  8 in total

Review 1.  A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19).

Authors:  Ayushi Rastogi; Abhilasha Singh; Kaustubh Naik; Archana Mishra; Shilpi Chaudhary; Rajiv Manohar; Avanish Singh Parmar
Journal:  J Mol Liq       Date:  2022-07-08       Impact factor: 6.633

2.  Electrostatic Spray Disinfection Using Nano-Engineered Solution on Frequently Touched Surfaces in Indoor and Outdoor Environments.

Authors:  Tanya Purwar; Shamya Dey; Osama Zaid Ali Al-Kayyali; Aaron Floyd Zalar; Ali Doosttalab; Luciano Castillo; Victor M Castano
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

Review 3.  A review of the phytochemical mediated synthesis of AgNP (silver nanoparticle): the wonder particle of the past decade.

Authors:  Wasim Akram Shaikh; Sukalyan Chakraborty; Gary Owens; Rafique Ul Islam
Journal:  Appl Nanosci       Date:  2021-10-30       Impact factor: 3.869

Review 4.  Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities.

Authors:  Elidamar Nunes de Carvalho Lima; Ana Luiza Moraes Octaviano; José Roberto Castilho Piqueira; Ricardo Sobhie Diaz; João Francisco Justo
Journal:  Int J Nanomedicine       Date:  2022-02-21

Review 5.  Forecasting the Post-Pandemic Effects of the SARS-CoV-2 Virus Using the Bullwhip Phenomenon Alongside Use of Nanosensors for Disease Containment and Cure.

Authors:  Mohammed S Alqahtani; Mohamed Abbas; Mohammed Abdulmuqeet; Abdullah S Alqahtani; Mohammad Y Alshahrani; Abdullah Alsabaani; Murugan Ramalingam
Journal:  Materials (Basel)       Date:  2022-07-21       Impact factor: 3.748

Review 6.  Development of gold nanoparticle-based biosensors for COVID-19 diagnosis.

Authors:  Johra Khan; Yousef Rasmi; Kevser Kübra Kırboğa; Ahmad Ali; Mithun Rudrapal; Rohan R Patekar
Journal:  Beni Suef Univ J Basic Appl Sci       Date:  2022-09-05

Review 7.  Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment.

Authors:  Wei Zhu; Zhanqi Wei; Chang Han; Xisheng Weng
Journal:  Nanomaterials (Basel)       Date:  2021-12-10       Impact factor: 5.076

8.  Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach.

Authors:  Miroslava Nedyalkova; Mahdi Vasighi; Subrahmanyam Sappati; Anmol Kumar; Sergio Madurga; Vasil Simeonov
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.